Condition (MeSH)
Aicardi Syndrome
ClinicalTrials.gov lists 3 trials for Aicardi Syndrome or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
3 of the 3 trials are tagged with Aicardi Syndrome itself; the rest are tagged with a narrower condition beneath it.
When did Aicardi Syndrome trials start? (3)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2015 | 1 |
| 2003 | 1 |
| 2002 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 3 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Aicardi Syndrome trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Not applicable | 1 |
| Observational | 2 |
How many Aicardi Syndrome trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 2 |
| Completed | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Aicardi Syndrome? (5)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes. | Epilepsy & behavior : E&B | 2018 | Yes |
| Ophthalmologic findings in Aicardi syndrome. | Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus | 2012 | Yes |
| Diffusion tensor imaging of Aicardi syndrome. | Pediatric neurology | 2010 | Yes |
| Identification of genomic loci contributing to agenesis of the corpus callosum. | American journal of medical genetics. Part A | 2010 | Yes |
| Brain abnormalities on MR imaging in patients with retinoblastoma. | AJNR. American journal of neuroradiology | 2010 | No |
Prevalence (12)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Aicardi syndrome | Prevalence at birth | 1-9 / 1 000 000 | United States | US | Unspecified |
| Aicardi syndrome | Point prevalence | 1-9 / 1 000 000 | United States | US | Exact |
| Aicardi syndrome | Prevalence at birth | 1-9 / 1 000 000 | United States | US | Exact |
| Aicardi syndrome | Point prevalence | 1-9 / 1 000 000 | United States | US | Unspecified |
| Aicardi syndrome | Point prevalence | 1-9 / 1 000 000 | United States | US | Exact |
Showing 5 of 12 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Aicardi syndrome | 50 | Exact | Orphadata Science knowledge files, Product 1 |
| Aicardi syndrome | 50 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.